Patents by Inventor Frédéric Sedel

Frédéric Sedel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING DEMYELINATING NEUROPATHY WITH BIOTIN
    Publication number: 20190314342
    Abstract: The invention relates to the use of biotin for treating Amyotrophic Lateral Sclerosis, as well as demyelinating peripheral neuropathies and Neuromyelitis optica (NMO).
    Type: Application
    Filed: June 25, 2019
    Publication date: October 17, 2019
    Applicant: MedDay Pharmaceuticals
    Inventor: Frédéric SEDEL
  • Biotin for treating peripheral demyelinating neuropathy
    Patent number: 10357480
    Abstract: The invention relates to the use of biotin for treating Amyotrophic Lateral Sclerosis, as well as demyelinating peripheral neuropathies and Neuromyelitis optica (NMO).
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: July 23, 2019
    Assignee: MEDDAY PHARMACEUTICALS
    Inventor: Frédéric Sedel
  • Method for treating hepatic encephalopathy
    Patent number: 10328059
    Abstract: A method of treating or preventing type C Hepatic Encephalopathy in a human patient diagnosed with cirrhosis by administering a composition containing at least 200 mg biotin to the human patient daily.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: June 25, 2019
    Assignee: MEDDAY PHARMACEUTICALS
    Inventor: Frédéric Sedel
  • METHOD OF TREATING MULTIPLE SCLEROSIS
    Publication number: 20190134006
    Abstract: The invention provides a composition for oral administration that is formulated for human administration in unit dosage form and contains as its sole active ingredient at least 100 mg biotin per unit dose.
    Type: Application
    Filed: December 31, 2018
    Publication date: May 9, 2019
    Applicant: Assistance Publique Hopitaux De Paris
    Inventors: Frédéric Sedel, Agnès BELLANGER
  • METHOD OF TREATING MULTIPLE SCLEROSIS
    Publication number: 20190117625
    Abstract: The invention provides a composition for oral administration that is formulated for human administration in unit dosage form and contains as its sole active ingredient at least 100 mg biotin per unit dose.
    Type: Application
    Filed: December 21, 2018
    Publication date: April 25, 2019
    Applicant: Assistance Publique Hopitaux De Paris
    Inventor: Frédéric SEDEL
  • METHOD OF TREATING MULTIPLE SCLEROSIS
    Publication number: 20190117626
    Abstract: The invention provides a composition for oral administration that is formulated for human administration in unit dosage form and contains as its sole active ingredient at least 100 mg biotin per unit dose.
    Type: Application
    Filed: December 21, 2018
    Publication date: April 25, 2019
    Applicant: Assistance Publique Hopitaux De Paris
    Inventor: Frédéric SEDEL
  • METHOD FOR TREATING HEPATIC ENCEPHALOPATHY
    Publication number: 20190070150
    Abstract: A method of treating or preventing type C Hepatic Encephalopathy in a human patient diagnosed with cirrhosis by administering a composition containing at least 200 mg biotin to the human patient daily.
    Type: Application
    Filed: September 18, 2018
    Publication date: March 7, 2019
    Applicant: MEDDAY PHARMACEUTICALS
    Inventor: Frédéric SEDEL
  • Method of treating multiple sclerosis
    Patent number: 10201528
    Abstract: The invention provides methods for treating multiple sclerosis by administering biotin. The invention also provides methods for treating sequelae after multiple sclerosis attacks by administering biotin.
    Type: Grant
    Filed: April 12, 2016
    Date of Patent: February 12, 2019
    Assignee: Assistance Publique Hopitaux De Paris
    Inventor: Frédéric Sedel
  • Method for treating hepatic encephalopathy
    Patent number: 10117854
    Abstract: A method of treating or preventing type C Hepatic Encephalopathy in a human patient diagnosed with cirrhosis by administering a composition containing at least 200 mg biotin to the human patient daily.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: November 6, 2018
    Assignee: MEDDAY PHARMACEUTICALS
    Inventor: Frédéric Sedel
  • METHOD FOR TREATING HEPATIC ENCEPHALOPATHY
    Publication number: 20180214417
    Abstract: A method of treating or preventing type C Hepatic Encephalopathy in a human patient diagnosed with cirrhosis by administering a composition containing at least 200 mg biotin to the human patient daily.
    Type: Application
    Filed: March 26, 2018
    Publication date: August 2, 2018
    Applicant: MEDDAY PHARMACEUTICALS
    Inventor: Frédéric SEDEL
  • BIOTIN FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
    Publication number: 20180125825
    Abstract: The invention relates to the use of biotin for treating Amyotrophic Lateral Sclerosis, as well as demyelinating peripheral neuropathies and Neuromyelitis optica (NMO).
    Type: Application
    Filed: March 25, 2016
    Publication date: May 10, 2018
    Applicant: MedDay Pharmaceuticals
    Inventor: Frédéric SEDEL
  • Biotin for use in treating X-linked adrenoleukodystrophy
    Patent number: 9789092
    Abstract: The invention relates to the use of biotin for treating X-linked adrenoleukodistrophy, in particular adrenomyeloneuropathy.
    Type: Grant
    Filed: January 14, 2014
    Date of Patent: October 17, 2017
    Assignee: Assistance Publique—Hopitaux de Paris
    Inventor: Frédéric Sedel
  • Method of Treating Multiple Sclerosis
    Publication number: 20160324830
    Abstract: The invention provides methods for treating multiple sclerosis by administering biotin. The invention also provides methods for treating sequelae after multiple sclerosis attacks by administering biotin.
    Type: Application
    Filed: April 12, 2016
    Publication date: November 10, 2016
    Applicant: Assistance Publique Hopitaux De Paris
    Inventor: Frédéric Sedel
  • Method of treating multiple sclerosis
    Patent number: 9351961
    Abstract: The invention provides methods for treating multiple sclerosis by administering biotin. The invention also provides methods for treating sequelae after multiple sclerosis attacks by administering biotin.
    Type: Grant
    Filed: August 13, 2014
    Date of Patent: May 31, 2016
    Assignee: Assistance Publique Hopitaux De Paris
    Inventor: Frédéric Sedel
  • BIOTIN FOR USE IN TREATING X-LINKED ADRENOLEUKODYSTROPHY
    Publication number: 20160074369
    Abstract: The invention relates to the use of biotin for treating X-linked adrenoleukodistrophy, in particular adrenomyeloneuropathy.
    Type: Application
    Filed: January 14, 2014
    Publication date: March 17, 2016
    Applicant: Assistance Publique - Hopitaux de Paris
    Inventor: Frédéric SEDEL
  • Method of Treating Multiple Sclerosis
    Publication number: 20140348920
    Abstract: The invention provides methods for treating multiple sclerosis by administering biotin. The invention also provides methods for treating sequelae after multiple sclerosis attacks by administering biotin.
    Type: Application
    Filed: August 13, 2014
    Publication date: November 27, 2014
    Applicant: ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
    Inventor: Frédéric Sedel
  • Method of treating multiple sclerosis
    Patent number: 8835487
    Abstract: The invention provides methods for treating multiple sclerosis by administering biotin. The invention also provides methods for treating sequalae after multiple sclerosis attacks by administering biotin.
    Type: Grant
    Filed: October 4, 2012
    Date of Patent: September 16, 2014
    Assignee: Assistance Publique Hopitaux De Paris
    Inventor: Frédéric Sedel
  • METHOD OF TREATING MULTIPLE SCLEROSIS
    Publication number: 20140030331
    Abstract: The invention provides methods for treating multiple sclerosis by administering biotin. The invention also provides methods for treating sequalae after multiple sclerosis attacks by administering biotin.
    Type: Application
    Filed: October 4, 2012
    Publication date: January 30, 2014
    Applicant: ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
    Inventor: Frédéric Sedel
  • PHARMACEUTICAL COMPOSITIONS HIGHLY DOSED WITH BIOTIN
    Publication number: 20130084334
    Abstract: The invention relates to novel pharmaceutical compositions highly dosed with biotin, as well as to the use thereof in treating visual impairments which are related, in particular, to optic atrophy.
    Type: Application
    Filed: April 5, 2011
    Publication date: April 4, 2013
    Applicant: Assistance Publique - Hopitaux de Paris
    Inventors: Frédéric Sedel, Agnès Bellanger